COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 34 filers reported holding COCRYSTAL PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $259,000 | -28.8% | 888,742 | 0.0% | 0.00% | – |
| Q2 2022 | $364,000 | -40.4% | 888,742 | -20.0% | 0.00% | – |
| Q1 2022 | $611,000 | -16.3% | 1,111,008 | -1.1% | 0.00% | – |
| Q4 2021 | $730,000 | -37.6% | 1,123,594 | +0.9% | 0.00% | – |
| Q3 2021 | $1,169,000 | -17.8% | 1,113,765 | -2.1% | 0.00% | – |
| Q2 2021 | $1,422,000 | -7.6% | 1,137,831 | +2.8% | 0.00% | – |
| Q1 2021 | $1,539,000 | +2.3% | 1,106,970 | 0.0% | 0.00% | – |
| Q4 2020 | $1,505,000 | +5688.5% | 1,106,970 | +2934.2% | 0.00% | – |
| Q1 2020 | $26,000 | +62.5% | 36,483 | +10.4% | 0.00% | – |
| Q4 2019 | $16,000 | -76.5% | 33,061 | -1.0% | 0.00% | – |
| Q3 2019 | $68,000 | -18.1% | 33,409 | -5.4% | 0.00% | – |
| Q2 2019 | $83,000 | -1.2% | 35,323 | +15.3% | 0.00% | – |
| Q1 2019 | $84,000 | -28.8% | 30,638 | -6.4% | 0.00% | – |
| Q4 2018 | $118,000 | +42.2% | 32,738 | -1.8% | 0.00% | – |
| Q3 2018 | $83,000 | -29.1% | 33,338 | +4.2% | 0.00% | – |
| Q2 2018 | $117,000 | – | 31,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 5,612,037 | $3,087,000 | 0.46% |
| Parallel Advisors, LLC | 182,708 | $102,000 | 0.00% |
| Clean Yield Group | 5,000 | $3,000 | 0.00% |
| Verition Fund Management LLC | 160,000 | $88,000 | 0.00% |
| Renaissance Technologies | 1,704,328 | $937,000 | 0.00% |
| Virtu Financial LLC | 14,237 | $8,000 | 0.00% |
| Western Wealth Management, LLC | 22,815 | $13,000 | 0.00% |
| BRIGHTON JONES LLC | 28,000 | $15,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 107,695 | $59,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 965 | $0 | 0.00% |